Literature DB >> 33436531

The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017.

Mimi Zhai1, Jianhai Long2, Sushun Liu3, Chun Liu3, Li Li3, Leping Yang3, Yamin Li1,4, Bo Shu3.   

Abstract

BACKGROUND: To evaluate the pattern and prevalence trends of liver cirrhosis caused by specific etiologies.
RESULTS: Globally, the number of prevalent cases increased 74.53% from 1990 to 2017. The ASR increased 0.75 per year. The most pronounced increases were found in middle-high and high socio-demographic index (SDI) regions, especially in the Caribbean and Latin America. Among the etiologies, non-alcoholic steatohepatitis (NASH) related liver cirrhosis accounted for 59.46% of the cases. The ASR increased 1.74 per year, and the increase was observed in all 5 SDI regions. In addition, the ASR of liver cirrhosis caused by alcohol also increased in both sexes and all SDI regions. In contrast, the ASR of liver cirrhosis caused by hepatitis B virus (HBV) and hepatitis C virus (HCV) decreased, especially in middle and low-middle SDI regions.
CONCLUSIONS: Though the number of people suffering from HBV and HCV decreases, liver cirrhosis is still a major threat to health. Additionally, the number of people with cirrhosis caused by alcohol and NASH continues to grow. Thus, more targeted and specific strategies should be established based on etiology and prevalence trends of liver cirrhosis.
METHODS: We collected data based on Global Burden of Disease (GBD) 2017 study. The age standardized prevalence rate (ASR) and estimated annual percentage changes (EAPC) were used to estimate the trends in prevalence by population, etiologies and regions.

Entities:  

Keywords:  etiology; global burden of disease study; liver cirrhosis

Mesh:

Year:  2021        PMID: 33436531      PMCID: PMC7835066          DOI: 10.18632/aging.104127

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  33 in total

1.  Partitioning linear trends in age-adjusted rates.

Authors:  B F Hankey; L A Ries; C L Kosary; E J Feuer; R M Merrill; L X Clegg; B K Edwards
Journal:  Cancer Causes Control       Date:  2000-01       Impact factor: 2.506

Review 2.  Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-12-16

3.  The epidemiology of hepatitis B and hepatitis C infections in China from 2004 to 2014: An observational population-based study.

Authors:  Z Liu; Q Yang; O Shi; W Ye; X Chen; T Zhang
Journal:  J Viral Hepat       Date:  2018-06-20       Impact factor: 3.728

4.  The Triumph of Bacchus: The Emergence of Nonalcoholic Steatohepatitis and Alcoholic Liver Disease as the Leading Causes of Mortality From Cirrhosis.

Authors:  Thomas G Cotter; Michael R Charlton
Journal:  Hepatology       Date:  2019-02-19       Impact factor: 17.425

5.  Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Michael Roerecke; Afshin Vafaei; Omer S M Hasan; Bethany R Chrystoja; Marcus Cruz; Roy Lee; Manuela G Neuman; Jürgen Rehm
Journal:  Am J Gastroenterol       Date:  2019-10       Impact factor: 10.864

Review 6.  Management of HBV and HBV/HDV-Associated Liver Cirrhosis.

Authors:  Christoph Höner Zu Siederdissen; Markus Cornberg
Journal:  Visc Med       Date:  2016-04-12

7.  The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.

Authors:  Zhenqiu Liu; Yanfeng Jiang; Huangbo Yuan; Qiwen Fang; Ning Cai; Chen Suo; Li Jin; Tiejun Zhang; Xingdong Chen
Journal:  J Hepatol       Date:  2018-12-11       Impact factor: 25.083

Review 8.  Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Authors:  Aparna Schweitzer; Johannes Horn; Rafael T Mikolajczyk; Gérard Krause; Jördis J Ott
Journal:  Lancet       Date:  2015-07-28       Impact factor: 79.321

Review 9.  The role of telomeres and telomerase in cirrhosis and liver cancer.

Authors:  Jean-Charles Nault; Massih Ningarhari; Sandra Rebouissou; Jessica Zucman-Rossi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-06-28       Impact factor: 46.802

Review 10.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2015-06-07       Impact factor: 202.731

View more
  1 in total

1.  Morbimortality Associated with Liver Cirrhosis in Peru: An Ecological Analysis for the Period of 2004-2016.

Authors:  Daniela Rojas-Acuña; Nilo Polo-Samillan; Angie Z Vasquez-Chavesta; Crist Escalante-Arias; Cristhian J Rios-Perez; Carlos J Toro-Huamanchumo
Journal:  Int J Environ Res Public Health       Date:  2022-07-25       Impact factor: 4.614

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.